← Back to Search

Cardiac Monitor

Reveal LINQ™ Insertable Cardiac Monitor for Stroke

N/A
Waitlist Available
Research Sponsored by Medtronic Cardiac Rhythm and Heart Failure
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Study Summary

This study is evaluating whether continuous cardiac rhythm monitoring can detect atrial fibrillation in people with a recent stroke.

Eligible Conditions
  • Stroke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The Rate of AF Through 12 Months in Subjects With a Recent Ischemic Stroke of Presumed Known Origin.
Secondary outcome measures
The Rate of AF Through the Duration of Study Follow-up (36 Months) Between Study Arms.

Trial Design

2Treatment groups
Active Control
Group I: Control ArmActive Control1 Intervention
Subjects randomized to the control arm will be followed per site specific standard of care.
Group II: Reveal LINQ™ Insertable Cardiac MonitorActive Control1 Intervention
Subjects randomized to the Reveal LINQ™ Insertable Cardiac Monitor arm will be continuously monitored via the inserted Reveal LINQ™ device.

Find a Location

Who is running the clinical trial?

Medtronic Cardiac Rhythm and Heart FailureLead Sponsor
198 Previous Clinical Trials
128,434 Total Patients Enrolled
2 Trials studying Stroke
3,547 Patients Enrolled for Stroke
Richard Bernstein, PhD/MDStudy ChairNorthwestern
Lee Schwamm, MDStudy ChairMass General
1 Previous Clinical Trials
88 Total Patients Enrolled
1 Trials studying Stroke
88 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Circulation: Cardiovascular Quality and OutcomesJournal
Influence of Hospital Characteristics on Hospital Transfer Destinations for Patients with Stroke
Zachrison, Kori S., Viviana Amati, Lee H. Schwamm, Zhiyu Yan, Victoria Nielsen, Anita Christie, Mathew J. Reeves, Joseph P. Sauser, Alessandro Lomi, and Jukka-Pekka Onnela. 2022. “Influence of Hospital Characteristics on Hospital Transfer Destinations for Patients with Stroke”. Circulation: Cardiovascular Quality and Outcomes. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circoutcomes.121.008269.
clinicaltrials.govStudy
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
2016. "Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02700945.
~55 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top